0001107421-12-000002.txt : 20121121 0001107421-12-000002.hdr.sgml : 20121121 20121121092823 ACCESSION NUMBER: 0001107421-12-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121121 DATE AS OF CHANGE: 20121121 EFFECTIVENESS DATE: 20121121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZIOPHARM ONCOLOGY INC CENTRAL INDEX KEY: 0001107421 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 841475642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-187344 FILM NUMBER: 121219765 BUSINESS ADDRESS: STREET 1: 1180 AVENUE OF THE AMERICA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-214-0700 MAIL ADDRESS: STREET 1: 1180 AVENUE OF THE AMERICA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: EASYWEB INC DATE OF NAME CHANGE: 20010213 D 1 primary_doc.xml X0706 D LIVE 0001107421 ZIOPHARM ONCOLOGY INC 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY NEW YORK 10036 646-214-0700 DELAWARE EASYWEB INC Corporation true Jonathan Lewis 1180 Avenue of the Americas 19th Floor New York NY NEW YORK 10036 Executive Officer Director Hagop Youssoufian 1180 Avenue of the Americas New York NY NEW YORK 10036 Executive Officer Murray Brennan Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY NEW YORK 10021 Director James Anthony Cannon BBDO 1285 Avenue of the Americas New York NY NEW YORK 10019 Director Wyche Fowler, Jr. 701 A Street NE Washington DC DISTRICT OF COLUMBIA 20002 Director Timothy McInerney One Coventry Lane Hopewell NJ NEW JERSEY 08525 Director Michael Weiser 1180 Avenue of the Americas 19th Floor New York NY NEW YORK 10036 Director Randal J Kirk 1881 Grove Avenue Radford VA VIRGINIA 24141 Director Jason A. Amello 1180 Avenue of the Americas 19th Floor New York NY NEW YORK 10036 Executive Officer Caesar J. Belbel 1180 Avenue of the Americas 19th Floor New York NY NEW YORK 10036 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2012-11-07 false true false 0 3637 3637 0 The total amount was deemed paid in partial consideration for the execution and delivery by Intrexon Corporation of the Exclusive Channel Partner Agreement, dated January 6, 2011. false 1 0 0 0 false ZIOPHARM ONCOLOGY INC /s/ Jason A. Amello Jason A. Amello Executive VP and CFO 2012-11-19